Bionyeri is developing a new generation of plant-based products to help relieve symptoms of pain for a range of health conditions to improve the quality of life and well-being for millions of humans.
Located in Sydney, Australia, we are focused on the advancement of natural products for pain management using resources traditionally used in Western medicine with the assistance of artificial intelligence and enhanced drug discovery mechanisms.
Our vision is to become a market leader in the development of natural products for pain relief which are backed by scientific evidence and experiments conducted from our PC2 accredited laboratory in Sydney, Australia.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 35 Leighton Pl, Unit 8,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.bionyeri.com
- Keywords
- Innovation, Nutraceuticals, Bioactive, Inflammation, Cancers, Pain, Endometriosis, Research Services, Research and Development, Human Primary Cell Models, AI, Nanotechnologies, Mental Health, Skincare, ORAC Testing.
- HQ
- Hornsby, New South Wales
Bionyeri Questions
Bionyeri's website is http://www.bionyeri.com
Bionyeri's LinkedIn profile is https://au.linkedin.com/company/bionyeri
Bionyeri has
4 employees.
View email and phone details for 4
employees at Bionyeri.
Bionyeri's industry is
Biotechnology Research
Bionyeri's top competitors are
Csiro,
Biomedical Technology Indonesia,
Soho Global Health,
Vesiculate,
Desamis,
Lestari Jamuku,
Sfi Health,
Boehringer Ingelheim,
Brain Vector,
Sysmex Asia Pacific.
Bionyeri's categories are Biotechnology Research
Bionyeri's founding year is 2023
